Breakthrough in treatment for Dupuytren's disease

Researchers at the Kennedy Institute, University of Oxford, led by Professor Jagdeep Nanchahal have demonstrated the efficacy of the anti-TNF drug adalimumab for patients with early stage Dupuytren's disease.

source https://medicalxpress.com/news/2022-04-breakthrough-treatment-dupuytren-disease.html